Paul W. Crawford
Experienced in Metabolic Acidosis

Dr. Paul W. Crawford

Nephrology
9730 S Western Ave, Suite 326, 
Evergreen Park, IL 
Accepting New Patients
Offers Telehealth
Experienced in Metabolic Acidosis
9730 S Western Ave, Suite 326, 
Evergreen Park, IL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Paul Crawford is a Nephrologist in Evergreen Park, Illinois. Dr. Crawford is rated as an Experienced provider by MediFind in the treatment of Metabolic Acidosis. His top areas of expertise are Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Nephrosclerosis, and Renovascular Hypertension. Dr. Crawford is currently accepting new patients.

His clinical research consists of co-authoring 4 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Nephrology
Licenses
Internal Medicine in IL
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

9730 S Western Ave, Suite 326, Evergreen Park, IL 60805

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases
Enrollment Status: Completed
Publish Date: June 03, 2025
Intervention Type: Drug
Study Phase: Phase 2
A Multi-Center, Randomized, Two-Cohort Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of CTAP101 (Calcifediol) Extended-Release Capsules to Treat Secondary Hyperparathyroidism in Subjects With Vitamin D Insufficiency and Chronic Kidney Disease Requiring Regular Hemodialysis.
A Multi-Center, Randomized, Two-Cohort Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of CTAP101 (Calcifediol) Extended-Release Capsules to Treat Secondary Hyperparathyroidism in Subjects With Vitamin D Insufficiency and Chronic Kidney Disease Requiring Regular Hemodialysis.
Enrollment Status: Terminated
Publish Date: March 30, 2025
Intervention Type: Drug
Study Drug: Calcifediol
Study Phase: Phase 2
A Double-Blind, Double Dummy, Randomized, Phase 1b, Nitrofurantoin Controlled, Repeat Oral Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Microbiological Response of GSK3882347 in Female Participants With Acute Uncomplicated Urinary Tract Infection
A Double-Blind, Double Dummy, Randomized, Phase 1b, Nitrofurantoin Controlled, Repeat Oral Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Microbiological Response of GSK3882347 in Female Participants With Acute Uncomplicated Urinary Tract Infection
Enrollment Status: Completed
Publish Date: January 28, 2025
Intervention Type: Drug
Study Drugs: GSK3882347, Nitrofurantoin
Study Phase: Phase 1
A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
Enrollment Status: Completed
Publish Date: April 02, 2024
Intervention Type: Drug
Study Drugs: Daprodustat, Darbepoetin Alpha
Study Phase: Phase 3
An Open-Label, Repeated-Dose Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Study of Oral CTAP101 Capsules, Immediate- Release (IR) Calcifediol, High-Dose Cholecalciferol, and Paricalcitol Plus Low-Dose Cholecalciferol in Patients With Secondary Hyperparathyroidism, Stage 3 or 4 Chronic Kidney Disease and Vitamin D Insufficiency
An Open-Label, Repeated-Dose Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Study of Oral CTAP101 Capsules, Immediate- Release (IR) Calcifediol, High-Dose Cholecalciferol, and Paricalcitol Plus Low-Dose Cholecalciferol in Patients With Secondary Hyperparathyroidism, Stage 3 or 4 Chronic Kidney Disease and Vitamin D Insufficiency
Enrollment Status: Completed
Publish Date: December 09, 2022
Intervention Type: Drug
Study Phase: Phase 4
A Multi-Center Open-label Investigation to Assess the Safety and Efficacy of Multiple Doses of DM199 in Patients With Chronic Kidney Disease
A Multi-Center Open-label Investigation to Assess the Safety and Efficacy of Multiple Doses of DM199 in Patients With Chronic Kidney Disease
Enrollment Status: Completed
Publish Date: March 31, 2022
Intervention Type: Drug
Study Drug: DM199
Study Phase: Phase 2
A Randomized, Open-label Study to Evaluate the Effect of Daprodustat on Blood Pressure in Subjects With Anemia Associated With Chronic Kidney Disease on Hemodialysis Switched From a Stable Dose of an Erythropoiesis-stimulating Agent
A Randomized, Open-label Study to Evaluate the Effect of Daprodustat on Blood Pressure in Subjects With Anemia Associated With Chronic Kidney Disease on Hemodialysis Switched From a Stable Dose of an Erythropoiesis-stimulating Agent
Enrollment Status: Completed
Publish Date: June 03, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 6 Less Clinical Trials

4 Total Publications

Ferric Citrate Dosing in Iron Deficiency Anemia in Nondialysis-Dependent Chronic Kidney Disease.
Ferric Citrate Dosing in Iron Deficiency Anemia in Nondialysis-Dependent Chronic Kidney Disease.
Journal: American journal of nephrology
Published: February 01, 2021
Similar Doctors
Advanced in Metabolic Acidosis
Dr. Myles S. Wolf
Nephrology
Advanced in Metabolic Acidosis
Dr. Myles S. Wolf
Nephrology
251 E Huron St, Northwestern Memorial Hospital - Galter Pavilion 18-250, 
Chicago, IL 
 (12.8 miles away)
312-695-9797
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Myles Wolf is a Nephrologist in Chicago, Illinois. Dr. Wolf is rated as a Distinguished provider by MediFind in the treatment of Metabolic Acidosis. His top areas of expertise are Hypophosphatemia, Chronic Kidney Disease, Hypercalcemia, Kidney Transplant, and Parathyroidectomy. Dr. Wolf is currently accepting new patients.

Advanced in Metabolic Acidosis
Dr. Tamara Isakova
Nephrology
Advanced in Metabolic Acidosis
Dr. Tamara Isakova
Nephrology
676 N St Clair St Ste 2025, Arkes Pavilion, 
Chicago, IL 
 (13.0 miles away)
312-695-0596
Experience:
23+ years
Languages Spoken:
English
See accepted insurances

Tamara Isakova is a Nephrologist in Chicago, Illinois. Dr. Isakova has been practicing medicine for over 23 years and is rated as a Distinguished provider by MediFind in the treatment of Metabolic Acidosis. Her top areas of expertise are Chronic Kidney Disease, Metabolic Acidosis, Calcinosis, Diabetic Nephropathy, and Kidney Transplant.

Advanced in Metabolic Acidosis
Dr. John R. Asplin
Nephrology
Advanced in Metabolic Acidosis
Dr. John R. Asplin
Nephrology
180 Harvester Dr Ste 110, 
Burr Ridge, IL 
 (12.9 miles away)
773-834-4064
Languages Spoken:
English

John Asplin is a Nephrologist in Burr Ridge, Illinois. Dr. Asplin is rated as a Distinguished provider by MediFind in the treatment of Metabolic Acidosis. His top areas of expertise are Kidney Stones, Metabolic Acidosis, Inborn Renal Aminoaciduria, Nephrocalcinosis, and Gastric Bypass.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Crawford's expertise for a condition
ConditionClose
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile